IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-39270-2.html
   My bibliography  Save this article

Unraveling the glycosylated immunopeptidome with HLA-Glyco

Author

Listed:
  • Georges Bedran

    (University of Gdansk
    University of Michigan)

  • Daniel A. Polasky

    (University of Michigan)

  • Yi Hsiao

    (Department of Computational Medicine and Bioinformatics)

  • Fengchao Yu

    (University of Michigan)

  • Felipe Veiga Leprevost

    (University of Michigan)

  • Javier A. Alfaro

    (University of Gdansk
    University of Victoria
    University of Edinburgh)

  • Marcin Cieslik

    (University of Michigan
    Department of Computational Medicine and Bioinformatics
    University of Michigan School of Medicine)

  • Alexey I. Nesvizhskii

    (University of Michigan
    Department of Computational Medicine and Bioinformatics)

Abstract

Recent interest in targeted therapies has been sparked by the study of MHC-associated peptides (MAPs) that undergo post-translational modifications (PTMs), particularly glycosylation. In this study, we introduce a fast computational workflow that merges the MSFragger-Glyco search algorithm with a false discovery rate control for glycopeptide analysis from mass spectrometry-based immunopeptidome data. By analyzing eight large-scale publicly available studies, we find that glycosylated MAPs are predominantly presented by MHC class II. Here, we present HLA-Glyco, a comprehensive resource containing over 3,400 human leukocyte antigen (HLA) class II N-glycopeptides from 1,049 distinct protein glycosylation sites. This resource provides valuable insights, including high levels of truncated glycans, conserved HLA-binding cores, and differences in glycosylation positional specificity between HLA allele groups. We integrate the workflow within the FragPipe computational platform and provide HLA-Glyco as a free web resource. Overall, our work provides a valuable tool and resource to aid the nascent field of glyco-immunopeptidomics.

Suggested Citation

  • Georges Bedran & Daniel A. Polasky & Yi Hsiao & Fengchao Yu & Felipe Veiga Leprevost & Javier A. Alfaro & Marcin Cieslik & Alexey I. Nesvizhskii, 2023. "Unraveling the glycosylated immunopeptidome with HLA-Glyco," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39270-2
    DOI: 10.1038/s41467-023-39270-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-39270-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-39270-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Patrick A. Ott & Zhuting Hu & Derin B. Keskin & Sachet A. Shukla & Jing Sun & David J. Bozym & Wandi Zhang & Adrienne Luoma & Anita Giobbie-Hurder & Lauren Peter & Christina Chen & Oriol Olive & Todd , 2017. "An immunogenic personal neoantigen vaccine for patients with melanoma," Nature, Nature, vol. 547(7662), pages 217-221, July.
    2. Michal Bassani-Sternberg & Eva Bräunlein & Richard Klar & Thomas Engleitner & Pavel Sinitcyn & Stefan Audehm & Melanie Straub & Julia Weber & Julia Slotta-Huspenina & Katja Specht & Marc E. Martignoni, 2016. "Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry," Nature Communications, Nature, vol. 7(1), pages 1-16, December.
    3. Elise Alspach & Danielle M. Lussier & Alexander P. Miceli & Ilya Kizhvatov & Michel DuPage & Adrienne M. Luoma & Wei Meng & Cheryl F. Lichti & Ekaterina Esaulova & Anthony N. Vomund & Daniele Runci & , 2019. "MHC-II neoantigens shape tumour immunity and response to immunotherapy," Nature, Nature, vol. 574(7780), pages 696-701, October.
    4. Giacomo Oliveira & Kari Stromhaug & Nicoletta Cieri & J. Bryan Iorgulescu & Susan Klaeger & Jacquelyn O. Wolff & Suzanna Rachimi & Vipheaviny Chea & Kate Krause & Samuel S. Freeman & Wandi Zhang & Shu, 2022. "Landscape of helper and regulatory antitumour CD4+ T cells in melanoma," Nature, Nature, vol. 605(7910), pages 532-538, May.
    5. Chloe Chong & Markus Müller & HuiSong Pak & Dermot Harnett & Florian Huber & Delphine Grun & Marion Leleu & Aymeric Auger & Marion Arnaud & Brian J. Stevenson & Justine Michaux & Ilija Bilic & Antje H, 2020. "Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes," Nature Communications, Nature, vol. 11(1), pages 1-21, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jens Bauer & Natalie Köhler & Yacine Maringer & Philip Bucher & Tatjana Bilich & Melissa Zwick & Severin Dicks & Annika Nelde & Marissa Dubbelaar & Jonas Scheid & Marcel Wacker & Jonas S. Heitmann & S, 2022. "The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Ashish Goyal & Jens Bauer & Joschka Hey & Dimitris N. Papageorgiou & Ekaterina Stepanova & Michael Daskalakis & Jonas Scheid & Marissa Dubbelaar & Boris Klimovich & Dominic Schwarz & Melanie Märklin &, 2023. "DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    3. Samuel Rivero-Hinojosa & Melanie Grant & Aswini Panigrahi & Huizhen Zhang & Veronika Caisova & Catherine M. Bollard & Brian R. Rood, 2021. "Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    4. Laura Y. Zhou & Fei Zou & Wei Sun, 2023. "Prioritizing candidate peptides for cancer vaccines through predicting peptide presentation by HLA‐I proteins," Biometrics, The International Biometric Society, vol. 79(3), pages 2664-2676, September.
    5. Jennifer G. Abelin & Erik J. Bergstrom & Keith D. Rivera & Hannah B. Taylor & Susan Klaeger & Charles Xu & Eva K. Verzani & C. Jackson White & Hilina B. Woldemichael & Maya Virshup & Meagan E. Olive &, 2023. "Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    6. John P. Finnigan & Jenna H. Newman & Yury Patskovsky & Larysa Patskovska & Andrew S. Ishizuka & Geoffrey M. Lynn & Robert A. Seder & Michelle Krogsgaard & Nina Bhardwaj, 2024. "Structural basis for self-discrimination by neoantigen-specific TCRs," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    7. Naomi Hoenisch Gravel & Annika Nelde & Jens Bauer & Lena Mühlenbruch & Sarah M. Schroeder & Marian C. Neidert & Jonas Scheid & Steffen Lemke & Marissa L. Dubbelaar & Marcel Wacker & Anna Dengler & Rei, 2023. "TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    8. Denise Lau & Sonal Khare & Michelle M. Stein & Prerna Jain & Yinjie Gao & Aicha BenTaieb & Tim A. Rand & Ameen A. Salahudeen & Aly A. Khan, 2022. "Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    9. Hanqing Liao & Carolina Barra & Zhicheng Zhou & Xu Peng & Isaac Woodhouse & Arun Tailor & Robert Parker & Alexia Carré & Persephone Borrow & Michael J. Hogan & Wayne Paes & Laurence C. Eisenlohr & Rob, 2024. "MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    10. Celina Tretter & Niklas Andrade Krätzig & Matteo Pecoraro & Sebastian Lange & Philipp Seifert & Clara Frankenberg & Johannes Untch & Gabriela Zuleger & Mathias Wilhelm & Daniel P. Zolg & Florian S. Dr, 2023. "Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    11. Teresa Maria Rosaria Noviello & Anna Maria Giacomo & Francesca Pia Caruso & Alessia Covre & Roberta Mortarini & Giovanni Scala & Maria Claudia Costa & Sandra Coral & Wolf H. Fridman & Catherine Sautès, 2023. "Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    12. Jia He & Chaoyu Wang & Xiao Fang & Junyao Li & Xueying Shen & Junxia Zhang & Cheng Peng & Hongjian Li & Sai Li & Jeffrey M. Karp & Rui Kuai, 2024. "Tuning the fluidity and protein corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    13. Zhigui Zuo & Hao Yin & Yu Zhang & Congying Xie & Qinyang Wang, 2023. "A cytotoxic T cell inspired oncolytic nanosystem promotes lytic cell death by lipid peroxidation and elicits antitumor immune responses," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    14. Livius Penter & Mehdi Borji & Adi Nagler & Haoxiang Lyu & Wesley S. Lu & Nicoletta Cieri & Katie Maurer & Giacomo Oliveira & Aziz M. Al’Khafaji & Kiran V. Garimella & Shuqiang Li & Donna S. Neuberg & , 2024. "Integrative genotyping of cancer and immune phenotypes by long-read sequencing," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    15. Charlotte Adams & Wassim Gabriel & Kris Laukens & Mario Picciani & Mathias Wilhelm & Wout Bittremieux & Kurt Boonen, 2024. "Fragment ion intensity prediction improves the identification rate of non-tryptic peptides in timsTOF," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    16. Jeppe Sejerø Holm & Samuel A. Funt & Annie Borch & Kamilla Kjærgaard Munk & Anne-Mette Bjerregaard & James L. Reading & Colleen Maher & Ashley Regazzi & Phillip Wong & Hikmat Al-Ahmadie & Gopa Iyer & , 2022. "Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    17. Meghana Pagadala & Timothy J. Sears & Victoria H. Wu & Eva Pérez-Guijarro & Hyo Kim & Andrea Castro & James V. Talwar & Cristian Gonzalez-Colin & Steven Cao & Benjamin J. Schmiedel & Shervin Goudarzi , 2023. "Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    18. Weilong Zhao & Xinwei Sher, 2018. "Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes," PLOS Computational Biology, Public Library of Science, vol. 14(11), pages 1-28, November.
    19. Haiwang Yang & Qianru Li & Emily K. Stroup & Sheng Wang & Zhe Ji, 2024. "Widespread stable noncanonical peptides identified by integrated analyses of ribosome profiling and ORF features," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    20. Laurel B. Darragh & Jacob Gadwa & Tiffany T. Pham & Benjamin Court & Brooke Neupert & Nicholas A. Olimpo & Khoa Nguyen & Diemmy Nguyen & Michael W. Knitz & Maureen Hoen & Sophia Corbo & Molishree Josh, 2022. "Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors," Nature Communications, Nature, vol. 13(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39270-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.